Uptal Patel is a Nephrology physician affiliated with Biogen. OpenAlex indexes 241 publications with 13,674 citations (h-index 56); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4101 N Roxboro St
Durham, NC 277042121
Telephone
919-684-8111Registry record last updated 8 Jul 2007.
Clinical trials
- Integrated Population Program for Diabetic Kidney Disease
Sponsor: Duke University
- Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Sponsor: Uptal Patel
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20231 payment
- Boston Scientific CorporationProgram year20221 payment
- BOSTON SCIENTIFIC CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2006–2016 per NIH RePORTER. The latest:
- Multi-factorial Intervention to Slow Progression of Diabetic Kidney Disease
Duke University
FY2015$682,611R01DK093938
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
New England Journal of Medicine
2024 - Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney
Journal of the American Society of Nephrology
2021 - International consensus definitions of clinical trial outcomes for kidney failure: 2020
Kidney International
2020 - Effects of Selonsertib in Patients with Diabetic Kidney Disease
Journal of the American Society of Nephrology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”